Latest Articles
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth - smallcaps.com.au
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth smallcaps.com.au
Published: April 28, 2026, 12:45 a.m.
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review - CancerNetwork
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review CancerNetwork
Published: April 27, 2026, 10:49 a.m.
Near-perfect disease control for bispecific in advanced endometrial cancer - MSN
Near-perfect disease control for bispecific in advanced endometrial cancer MSN
Published: April 27, 2026, 1:41 a.m.
Near-perfect disease control for bispecific in advanced endometrial cancer - msn.com
Near-perfect disease control for bispecific in advanced endometrial cancer msn.com
Published: April 27, 2026, 1:41 a.m.
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus - The ASCO Post
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus The ASCO Post
Published: April 26, 2026, 9 p.m.
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma - The ASCO Post
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma The ASCO Post
Published: April 26, 2026, 9 p.m.
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women - Diari ARA
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women Diari ARA
Published: April 26, 2026, 2:01 p.m.
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women - en.ara.cat
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women en.ara.cat
Published: April 26, 2026, 2:01 p.m.
Bindi Irwin details 'indescribable pain' and agony of 'invisible disease' in heartbreaking health update - MSN
Bindi Irwin details 'indescribable pain' and agony of 'invisible disease' in heartbreaking health update MSN
Published: April 26, 2026, 4:19 a.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - The Joplin Globe
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) The Joplin Globe
Published: April 24, 2026, 10:11 p.m.
Link copied to clipboard!